Saratoga Research & Investment Management Sells 85,311 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Saratoga Research & Investment Management cut its stake in shares of Roche Holding AG (OTCMKTS:RHHBY) by 3.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,325,810 shares of the company’s stock after selling 85,311 shares during the period. Roche accounts for 4.1% of Saratoga Research & Investment Management’s holdings, making the stock its 9th largest position. Saratoga Research & Investment Management’s holdings in Roche were worth $92,916,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Altrius Capital Management Inc grew its stake in shares of Roche by 6.0% in the second quarter. Altrius Capital Management Inc now owns 224,804 shares of the company’s stock valued at $7,794,000 after acquiring an additional 12,646 shares in the last quarter. Kornitzer Capital Management Inc. KS grew its position in shares of Roche by 1.3% during the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 136,923 shares of the company’s stock worth $5,490,000 after purchasing an additional 1,798 shares in the last quarter. Rhumbline Advisers increased its holdings in shares of Roche by 0.9% during the second quarter. Rhumbline Advisers now owns 103,985 shares of the company’s stock worth $3,605,000 after purchasing an additional 904 shares during the period. Bard Financial Services Inc. raised its position in shares of Roche by 156.8% in the third quarter. Bard Financial Services Inc. now owns 80,500 shares of the company’s stock valued at $3,216,000 after buying an additional 49,150 shares in the last quarter. Finally, Diversified Trust Co grew its position in Roche by 6.4% during the third quarter. Diversified Trust Co now owns 59,742 shares of the company’s stock worth $2,396,000 after buying an additional 3,613 shares in the last quarter.

Roche Stock Up 1.0 %

Roche stock opened at $36.00 on Thursday. The business has a 50 day moving average of $37.66 and a 200-day moving average of $37.71. Roche Holding AG has a 1 year low of $29.20 and a 1 year high of $42.43.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Bank of America raised shares of Roche from a “neutral” rating to a “buy” rating in a report on Friday, September 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Roche from a “hold” rating to a “sell” rating in a research report on Friday, September 13th. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, Roche currently has an average rating of “Hold”.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.